丹媚品牌怎么样 申请店铺

左炔诺孕酮肠溶片，肠溶片紧急补救避孕药品牌，专注于生殖健康用药、慢性病用药、外用药领域的研发、生产、销售的企业

广州朗圣药业有限公司（朗圣药业或Regenex）是一家专注于生殖健康用药、慢性病用药、外用药领域的研发、生产、销售于一体的高科技制药企业。公司成立于2003年，坐落于广州科学城，由留美海归人士卢智俊博士创办。厂区建筑面积26,362平方米，现有员工500余人，其中营销人员250余人，研发人员40余人。

公司2008年上市的生育控制领域内拥有自主知识产权的“丹媚”（左炔诺孕酮肠溶片）已通过2010年新版GMP认证。

公司营销中心秉承“客户至上、全员营销”的理念，以锐意进取的态度，在中国医药市场上建立有效、创新的营销、推广及品牌协同发展的新业务模式，对营销人员实行GPS轨迹管理，市场推广实行终端标准打法，售后实行 7×16小时专业背景的优质客户服务跟进。目前，营销中心已经培养出近百名区域管理人员及市场管理人员，以及拥有近五百名专业的营销、推广及市场人员，与全国超150个经销商建立合作伙伴关系，销售网络覆盖全中国。

公司的研发中心坚持“源头发制、系统创新”的研发战略，以新药研究开发为目标，以生殖健康领域的药物研发为主要方向，融信息、科研及中试为一体，目前在研各类新药项目达40项。先后承担了国家、省、市等科技项目20余项，申请发明专利20项（美国专利1项），其中已获授权10项。研发中心成功搭建了手性药物合成、注射脂质体靶向给药系统、口服缓控释给药系统、难溶性药物速释系统、复杂体系分析等技术平台。

Guangzhou Langsheng Pharmaceutical Co., Ltd. (Langsheng pharmaceutical or regenex) is a high-tech pharmaceutical company specializing in the research, development, production and sales of reproductive health medicine, chronic disease medicine and external medicine Enterprise. Founded in 2003, the company is located in Guangzhou Science City and founded by Dr. Lu Zhijun, a returnee from the United States. The building area of the plant is 26362 square meters, with more than 500 employees, including more than 250 marketing personnel and more than 40 R & D personnel. Danmei (levonorgestrel enteric coated tablets), which is listed in 2008 and has independent intellectual property rights in the field of birth control, has passed the new GMP certification in 2010. The company's marketing center adheres to the concept of "customer first, all staff marketing", with an enterprising attitude, establishes an effective and innovative new business model of marketing, promotion and brand coordinated development in the Chinese pharmaceutical market, implements GPS track management for marketing personnel, terminal standard operation for marketing promotion, and quality customer service follow-up with 7 × 16 hours of professional background after sales. At present, the marketing center has trained nearly 100 regional management personnel and marketing management personnel, as well as nearly 500 professional marketing, promotion and marketing personnel, and established partnerships with more than 150 dealers nationwide, with the sales network covering the whole China. The R & D center of the company adheres to the R & D strategy of "source development and system innovation", takes the research and development of new drugs as the goal, takes the research and development of drugs in the field of reproductive health as the main direction, and integrates information, scientific research and pilot test. At present, there are 40 new drug projects under research. It has successively undertaken more than 20 national, provincial and municipal science and technology projects, applied for 20 invention patents (1 American patent), of which 10 have been authorized. The R & D center has successfully built technical platforms for chiral drug synthesis, targeted drug delivery system for injection of liposomes, oral slow and controlled release drug delivery system, rapid release system for insoluble drugs, complex system analysis, etc.

本文链接： https://brand.waitui.com/2729d64fc.html 联系电话：02032086699